CUSIP H00263105SHSACIUQ4 2025
18 filings · latest Dec 13, 2024
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bvf Inc/Il | 19.82M | $62.24M |
| 2 | Wells Fargo & Company/Mn | 1.01M | $3.16M |
| 3 | Millennium Management LLC | 933.3K | $2.93M |
| 4 | Renaissance Technologies LLC | 668.9K | $2.10M |
| 5 | Blackrock, Inc. | 502.2K | $1.58M |
| 6 | Point72 Asset Management, L.P. | 384.8K | $1.21M |
| 7 | Arrowstreet Capital, Limited Partnership | 375.6K | $1.18M |
| 8 | Northern Trust Corp | 282.0K | $885.3K |
| 9 |
| 4 | Dec 19, 2023 | Biotechnology Value Fund L P | 13G/A | 7.7% | 7.65M | SEC |
| 5 | Feb 14, 2023 | Affiris AG In Liqu | 13G/A | 8.1% | 6.72M | SEC |
| 6 | Feb 14, 2023 | Biotechnology Value Fund L P | 13G/A | 4.8% | 3.98M | SEC |
| 7 | Feb 10, 2023 | Dievini Hopp Biotech Holding Gmbh & Co Kg | 13G/A | 19.5% | 16.32M | SEC |
| 8 | Jan 27, 2023 | Eli Lilly & Co | 13G/A | 4.3% | 3.62M | SEC |
| 9 | Feb 14, 2022 | Ecor1 Capital, LLC | 13G/A | 0.9% | 749.6K | SEC |
| 10 | Feb 14, 2022 | Biotechnology Value Fund L P | 13G/A | 5.0% | 3.65M | SEC |
See the full Schedule 13D/13G history for Ac Immune SA.
Unlock full history| Dimensional Fund Advisors LP |
| 213.5K |
| $670.4K |
| 10 | Ubs Group AG | 194.3K | $610.3K |